A drug used to treat deadly coronavirus infections in cats could potentially be an effective treatment against SARS-CoV-2, the virus behind the global coronavirus pandemic, according to a study.
The finding, published in the journal Nature Communications, paves the way for human clinical trials of the drug, a protease inhibitor called GC376.
“This drug is very likely to work in humans, so we are encouraged that it will be an effective treatment for COVID-19 patients,” said Joanne Lemieux, a professor at the University of Alberta in Canada.
However, the researchers said clinical trials will need to run their course before anyone can be sure that the drug is both safe and effective for treating COVID-19 in humans. – PTI